# Intramuscular CodaVax-H1N1 in Healthy Adults

> **NCT05223179** · PHASE1 · COMPLETED · sponsor: **Codagenix, Inc** · enrollment: 69 (actual)

## Conditions studied

- Influenza, Human

## Interventions

- **BIOLOGICAL:** CODA-VAX H1N1
- **BIOLOGICAL:** Flucelvax Quad
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT05223179
- **Lead sponsor:** Codagenix, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-11
- **Primary completion:** 2024-02-09
- **Final completion:** 2024-02-09
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05223179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05223179, "Intramuscular CodaVax-H1N1 in Healthy Adults". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05223179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*